{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T23:11:02Z","timestamp":1761606662958,"version":"build-2065373602"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T00:00:00Z","timestamp":1634256000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["2019"],"award-info":[{"award-number":["2019"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.jchromb.2021.122989","type":"journal-article","created":{"date-parts":[[2021,10,14]],"date-time":"2021-10-14T03:48:57Z","timestamp":1634183337000},"page":"122989","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Application of liquid chromatography coupled to data-independent acquisition mass spectrometry for the metabolic profiling of N-ethyl heptedrone"],"prefix":"10.1016","volume":"1185","author":[{"given":"Monica","family":"Mazzarino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristian","family":"Camuto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Comunit\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"de la Torre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlotta","family":"Stacchini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Botr\u00e8","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2021.122989_b0005","first-page":"00159","article-title":"A New Beginning: An Overview of New Psychoactive Substances","volume":"5","author":"O\u2019Hagan","year":"2017","journal-title":"Forensic Res. Criminol. Int. J."},{"issue":"2","key":"10.1016\/j.jchromb.2021.122989_b0010","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/2045125314559539","article-title":"Legal highs: Staying ontop of the flood of novel psychoactive substances","volume":"5","author":"Baumeister","year":"2015","journal-title":"Ther. Adv Psychopharmacol."},{"key":"10.1016\/j.jchromb.2021.122989_b0015","first-page":"89","article-title":"Legal highs: safe and legal heavens? A study on the diffusion, knowledge and risk awareness of novel psychoactive drugs among students in the UK","volume":"49","author":"Corazza","year":"2014","journal-title":"Riv. Psichiatr."},{"issue":"7","key":"10.1016\/j.jchromb.2021.122989_b0020","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1080\/10408444.2019.1679087","article-title":"Synthetic cathinones: an evolving class of new psychoactive substances","volume":"49","author":"Gon\u00e7alves","year":"2019","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.jchromb.2021.122989_b0025","doi-asserted-by":"crossref","first-page":"12","DOI":"10.2174\/1570159X13666141210224137","article-title":"Synthetic Cathinones: A New Public Health Problem","volume":"13","author":"Karila","year":"2015","journal-title":"Cur. Neuropharmacol."},{"issue":"1","key":"10.1016\/j.jchromb.2021.122989_b0030","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.lfs.2013.07.023","article-title":"Bath salts and synthetic cathinones: an emerging designer drug phenomenon","volume":"97","author":"German","year":"2014","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.jchromb.2021.122989_b0035","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00204-013-1163-9","article-title":"Khat and synthetic cathinones: A review","volume":"88","author":"Valente","year":"2014","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.jchromb.2021.122989_b0040","first-page":"37","article-title":"Emerging drugs of abuse: current perspectives on substituted cathinones","volume":"5","author":"Paillet-Loilier","year":"2014","journal-title":"Subst. Abuse Rehabil."},{"issue":"1-3","key":"10.1016\/j.jchromb.2021.122989_b0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2012.11.020","article-title":"Psychoactive \u201cbath salts\u201d: not so soothing","volume":"698","author":"Baumann","year":"2013","journal-title":"Eur. J. Pharmacol."},{"issue":"1-3","key":"10.1016\/j.jchromb.2021.122989_b0050","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.forsciint.2013.04.015","article-title":"Designer cathinones-an emerging class of novel recreational drugs","volume":"231","author":"Zawilska","year":"2013","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.jchromb.2021.122989_b0055","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/dta.313","article-title":"Cathinone derivatives: A review of their chemistry, pharmacology and toxicology","volume":"3","author":"Kelly","year":"2011","journal-title":"Drug Test. Anal."},{"issue":"2","key":"10.1016\/j.jchromb.2021.122989_b0060","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1476-5381.2012.02145.x","article-title":"Pharmacological characterization of designer cathinones in vitro","volume":"168","author":"Simmler","year":"2013","journal-title":"Br. J. Pharmacol."},{"issue":"1-2","key":"10.1016\/j.jchromb.2021.122989_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2013.06.016","article-title":"Clinical and pharmacological aspects of bath salt use: A review of the literature and case reports","volume":"132","author":"Miotto","year":"2013","journal-title":"Drug Alcohol Depend."},{"issue":"2","key":"10.1016\/j.jchromb.2021.122989_b0070","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.toxlet.2012.03.009","article-title":"Synthetic cathinones: Chemistry, pharmacology and toxicology of a new class of designer drugs of abuse marketed as \u201cbath salts\u201d or \u201cplant food\u201d","volume":"211","author":"Coppola","year":"2012","journal-title":"Toxicol. Lett."},{"issue":"1","key":"10.1016\/j.jchromb.2021.122989_b0075","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.lfs.2013.10.033","article-title":"Behavioral pharmacology of designer cathinones: A review of the preclinical literature","volume":"97","author":"Gregg","year":"2014","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.jchromb.2021.122989_b0080","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s13181-011-0193-z","article-title":"The toxicology of bath salts: A review of synthetic cathinones","volume":"8","author":"Prosser","year":"2012","journal-title":"J. Med. Toxicol."},{"key":"10.1016\/j.jchromb.2021.122989_b0085","first-page":"30","article-title":"A review on synthetic cathinone and its derivatives: Analyses and legal status, Malaysian","volume":"6","author":"Abdullah","year":"2015","journal-title":"J. Forensic Sci."},{"key":"10.1016\/j.jchromb.2021.122989_b0090","first-page":"1040","article-title":"Synthetic Cathinones: A Brief Overview of Overviews with Applications to the Forensic Sciences","volume":"4","author":"Glennon","year":"2017","journal-title":"Ann. Forensic Res. Anal."},{"issue":"5","key":"10.1016\/j.jchromb.2021.122989_b0095","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1080\/10408347.2018.1439724","article-title":"The analytical challenge in the determination of cathinones, key-players in the worldwide phenomenon of novel psychoactive substances","volume":"48","author":"Couto","year":"2018","journal-title":"Crit. Rev. Anal. Chem."},{"key":"10.1016\/j.jchromb.2021.122989_b0100","unstructured":"https:\/\/www.swgdrug.org\/Monographs\/N-ethyl%20heptedrone.pdf."},{"key":"10.1016\/j.jchromb.2021.122989_b0105","unstructured":"The World Anti-Doping Code. The 2021 Prohibited List International Standard. World Anti-Doping Agency, Montreal, Canada. Available at: www.wada-ama.org. Accessed 17 June 2021."},{"issue":"8","key":"10.1016\/j.jchromb.2021.122989_b0110","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/0165-6147(93)90043-J","article-title":"In vitro approaches can predict human drug metabolism","volume":"14","author":"Birkett","year":"1993","journal-title":"Trends in Pharmacol. Sci."},{"issue":"2","key":"10.1016\/j.jchromb.2021.122989_b0115","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0163-7258(96)00184-2","article-title":"Prediction of in vivo drug metabolism in the human liver from in vitro metabolism data","volume":"73","author":"Iwatsubo","year":"1997","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jchromb.2021.122989_b0120","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0887-2333(03)00120-6","article-title":"Drugs of Abuse and Abuse of Drugs in Sportsmen: The Role of In Vitro Methods to Study Effect and Mechanism","volume":"17","author":"Botr\u00e8","year":"2003","journal-title":"Toxicol. In Vitro"},{"issue":"1","key":"10.1016\/j.jchromb.2021.122989_b0125","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.pmr.2008.10.010","article-title":"Enhancement drugs and the athlete","volume":"20","author":"Botr\u00e8","year":"2009","journal-title":"Phys. Med. Rehabil. Clin. N. Am."},{"issue":"1","key":"10.1016\/j.jchromb.2021.122989_b0130","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2133\/dmpk.25.16","article-title":"System-dependent outcomes during the evaluation of drug candidates as inhibitors of cytochrome P450 (CYP) and uridine diphosphate glucuronosyltransferase (UGT) enzymes: human hepatocytes versus liver microsomes versus recombinant enzymes","volume":"25","author":"Parkinson","year":"2010","journal-title":"Drug Metab. Pharmacokinet."},{"issue":"1","key":"10.1016\/j.jchromb.2021.122989_b0135","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/dta.2900","article-title":"Urinary excretion profile of methiopropamine in mice following intraperitoneal administration: A liquid chromatography\u2013tandem mass spectrometry investigation","volume":"13","author":"Camuto","year":"2021","journal-title":"Drug Test. Anal."},{"issue":"1","key":"10.1016\/j.jchromb.2021.122989_b0140","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s11419-020-00544-9","article-title":"Metabolic profile of the synthetic drug 4, 4\u2032-dimethylaminorex in urine by LC\u2013MS-based techniques: selection of the most suitable markers of its intake","volume":"39","author":"Chieffi","year":"2021","journal-title":"Forensic Toxicol."},{"key":"10.1016\/j.jchromb.2021.122989_b0145","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.jpba.2017.06.054","article-title":"Characterization of the phase I and phase II metabolic profile of tolvaptan by in vitro studies and liquid chromatography\u2013mass spectrometry profiling: Relevance to doping control analysis","volume":"145","author":"Mazzarino","year":"2014","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"11-12","key":"10.1016\/j.jchromb.2021.122989_b0150","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1002\/dta.2538","article-title":"A further insight into the metabolic profile of the nuclear receptor Rev-erb agonist, SR9009","volume":"10","author":"Mazzarino","year":"2018","journal-title":"Drug Test. Anal."},{"issue":"6","key":"10.1016\/j.jchromb.2021.122989_b0155","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/rcm.4432","article-title":"Mass spectrometric characterization of tamoxifene metabolites in human urine utilizing different scan parameters on liquid chromatography\/tandem mass spectrometry","volume":"24","author":"Mazzarino","year":"2010","journal-title":"Rapid Comm. Mass Spectrom."},{"key":"10.1016\/j.jchromb.2021.122989_b0160","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.aca.2014.06.003","article-title":"A liquid chromatography\u2013mass spectrometry method based on class characteristic fragmentation pathways to detect the class of indole-derivative synthetic cannabinoids in biological samples","volume":"837","author":"Mazzarino","year":"2014","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.jchromb.2021.122989_b0165","unstructured":"ISO - ISO\/IEC 17025:2017 - General requirements for the competence of testing and calibration laboratories. https:\/\/www.iso.org\/standard\/66912.html. Accessed 13th June 2021."},{"key":"10.1016\/j.jchromb.2021.122989_b0170","unstructured":"International Standard for Laboratories (ISL) | World Anti-Doping Agency. https:\/\/www.wada-ama.org\/en\/resources\/laboratories\/international-standard-for-laboratories-isl. Accessed 13th June 2021."},{"key":"10.1016\/j.jchromb.2021.122989_b0175","unstructured":"World Anti-Doping Agency.WADA Technical Document TD2015IDCR. http:\/\/www.wada-ama.org. (Last accessed Accessed 13th June 2021)."},{"key":"10.1016\/j.jchromb.2021.122989_b0180","doi-asserted-by":"crossref","unstructured":"B K Matuszewski1,M L Constanzer,C M Chavez-Eng, Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS\/MS, 75(13) (2003) 3019-3030. https:\/\/doi.org\/10.1021\/ac020361s.","DOI":"10.1021\/ac020361s"},{"key":"10.1016\/j.jchromb.2021.122989_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2020.122340","article-title":"Metabolism of N-ethylhexedrone and buphedrone: An in vivo study in mice using HPLC-MS\/MS","volume":"1159","author":"Carrola","year":"2020","journal-title":"J. Chromatogr. B"},{"issue":"2","key":"10.1016\/j.jchromb.2021.122989_b0190","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1124\/dmd.114.061416","article-title":"Mass Spectrometric Evaluation of Mephedrone In Vivo Human Metabolism: Identification of Phase I and Phase II Metabolites, Including a Novel Succinyl Conjugate","volume":"43","author":"Pozo","year":"2015","journal-title":"Drug Metab Dispos"}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023221004700?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023221004700?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T23:06:29Z","timestamp":1761606389000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023221004700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":38,"alternative-id":["S1570023221004700"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2021.122989","relation":{},"ISSN":["1570-0232"],"issn-type":[{"type":"print","value":"1570-0232"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Application of liquid chromatography coupled to data-independent acquisition mass spectrometry for the metabolic profiling of N-ethyl heptedrone","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2021.122989","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"122989"}}